Skymap Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.01 Cr
About Skymap Lifesciences
Skymap Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 December 2022 (Two years and one month 26 days old ). Its registered office is in South West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹50.01 Cr.
Sanjay Gupta and Meenakshi Gupta serve as directors at the Company.
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230DL2022PTC408893
- Company No.
408893
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Skymap Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta  | Director | 27-Dec-2022 | Current |
| Meenakshi Gupta | Director | 27-Dec-2022 | Current |
Financial Performance of Skymap Lifesciences.
Skymap Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Skymap Lifesciences?
In 2023, Skymap Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glensmith Labs Private LimitedSanjay Gupta is a mutual person
Skymap Packaging Private LimitedSanjay Gupta and Meenakshi Gupta are mutual person
- Skymap Pharmaceuticals Private Limited
Sanjay Gupta is a mutual person
- Skymap Welfare Foundation
Sanjay Gupta and Meenakshi Gupta are mutual person
Mks Healthcare LlpSanjay Gupta and Meenakshi Gupta are mutual person
- Cosmax Pharma Llp
Sanjay Gupta is a mutual person
Charges (Loans)
₹50.01 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 50.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Apr 2023 | Hdfc Bank Limited | ₹50.01 Cr | Open |
How Many Employees Work at Skymap Lifesciences?
Skymap Lifesciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skymap Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skymap Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.